At Close: Nov 27, 2023
Radcliffe Capital Management, L.P. Acquires Stake in Portage Fintech Acquisition Corp04:37pm, Thursday, 27'th Jul 2023
Radcliffe Capital Management, L.P. (Trades, Portfolio), a prominent investment firm, recently made a significant acquisition in the stock market.
NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins Fall12:57pm, Thursday, 11'th May 2023
NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.
NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript10:15pm, Wednesday, 10'th May 2023
NuVasive, Inc. (NASDAQ:NUVA ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Chris Barry - Chief Executive Officer
NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates06:59pm, Wednesday, 10'th May 2023
NuVasive (NUVA) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.54 per share a year ago.
Globus Medical: Still Very Attractive After NuVasive Selloff05:41am, Thursday, 04'th May 2023
Globus Medical caught headlines after announcing the NuVasive merger. Investors have wiped out considerable equity post-announcement, but the worst may be now priced in.
NUVA vs. ABT: Which Stock Is the Better Value Option?12:57pm, Tuesday, 25'th Apr 2023
Investors looking for stocks in the Medical - Products sector might want to consider either NuVasive (NUVA) or Abbott (ABT). But which of these two stocks is more attractive to value investors?
Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?12:59pm, Friday, 24'th Mar 2023
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock?
NuVasive's (NUVA) Precice System Cleared for Pediatric Patients09:13am, Tuesday, 21'st Mar 2023
NuVasive (NUVA) receives FDA 510(k) clearance for using the Precice limb lengthening system for treating pediatric patients.
NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth11:30am, Friday, 17'th Mar 2023
According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions.
NuVasive to Participate in Upcoming Investor Conferences04:10pm, Monday, 27'th Feb 2023
SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive (NUVA) Q4 Earnings Miss Estimates, Margins Down12:48pm, Thursday, 23'rd Feb 2023
Inflationary costs, supply chain disruptions, volatility in foreign exchange rates and the persistent COVID-led impact hurt NuVasive's (NUVA) Q4 revenues.
NuVasive, Inc. (NUVA) Q4 2022 Earnings Call Transcript09:08pm, Wednesday, 22'nd Feb 2023
NuVasive, Inc. (NASDAQ:NUVA ) Q4 2022 Earnings Conference Call February 22, 2023 4:30 PM ET Company Participants Juliet Cunningham - VP, IR Christopher Barry - CEO & Director Matthew Harbaugh - EVP &